Provera and Urocit-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Provera and Urocit-k. Common interactions include anaemia among females.

The phase IV clinical study analyzes what interactions people who take Provera and Urocit-k have. It is created by eHealthMe based on reports of 32 people who take Provera and Urocit-k from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

32 people who take Provera and Urocit-k together, and have interactions are studied.


What is Provera?

Provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 53,428 Provera users for its effectiveness, alternative drugs and more.

What is Urocit-k?

Urocit-k has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 623 Urocit-k users for its effectiveness, alternative drugs and more.

Number of Provera and Urocit-k reports submitted per year:

Provera and Urocit-k drug interactions.

Common Provera and Urocit-K drug interactions by gender *:

female:

  1. Anaemia
  2. Blood cholesterol increased
  3. Ageusia
  4. Chills
  5. Diarrhoea
  6. Food intolerance
  7. Oral discomfort
  8. Pyrexia
  9. Abdominal pain upper
  10. Device related infection

male:

n/a

Common Provera and Urocit-K drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaemia
  2. Blood cholesterol increased
  3. Ageusia
  4. Chills
  5. Diarrhoea
  6. Food intolerance
  7. Oral discomfort
  8. Pyrexia
  9. Abdominal pain upper
  10. Device related infection

60+:

n/a

Common conditions people have *:

  1. Osteopenia (a condition where bone mineral density is lower than normal): 16 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Provera and Urocit-k?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Provera and Urocit-k interactions:

Browse all drug interactions of Provera and Urocit-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Provera side effects:

Browse all side effects of Provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Provera interactions:

Browse all interactions between Provera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Urocit-k interactions:

Browse all interactions between Urocit-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate and potassium citrate (the active ingredients of Provera and Urocit-k, respectively), and Provera and Urocit-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Provera and Urocit-k.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: